(Q41486255)

1 October 2017

1 reference

title

Lipids, thrombosis and cardiovascular disease in diabetes (English)

1 reference

1 October 2017

1 reference

Yudkin JS

1

1 reference

1 October 2017

publication date

1 March 1997

1 reference

Proceedings of the Nutrition Society

1 October 2017

published in

1 reference

1 October 2017

volume

56

1 reference

1 October 2017

issue

1B

1 reference

1 October 2017

page(s)

273-280

1 reference

Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS19970031

21 January 2018

Identifiers

DOI

10.1079/PNS19970031

1 reference

1 October 2017

1 reference